Cargando…
Biochemistry-informed design selects potent siRNAs against SARS-CoV-2
RNA interference (RNAi) offers an efficient way to repress genes of interest, and it is widely used in research settings. Clinical applications emerged more recently, with 5 approved siRNAs (the RNA guides of the RNAi effector complex) against human diseases. The development of siRNAs against the SA...
Autores principales: | Houbron, Élisabeth, Mockly, Sophie, Rafasse, Sophia, Gros, Nathalie, Muriaux, Delphine, Seitz, Hervé |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243379/ https://www.ncbi.nlm.nih.gov/pubmed/37272117 http://dx.doi.org/10.1080/15476286.2023.2217400 |
Ejemplares similares
-
A rationalized definition of general tumor suppressor microRNAs excludes miR-34a
por: Mockly, Sophie, et al.
Publicado: (2022) -
siSPOTR: a tool for designing highly specific and potent siRNAs for human and mouse
por: Boudreau, Ryan L., et al.
Publicado: (2013) -
Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents
por: Tuaillon, Edouard, et al.
Publicado: (2022) -
Constructing the boundary between potent and ineffective siRNAs by MG-algorithm with C-features
por: Jia, Xingang, et al.
Publicado: (2022) -
Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)